CytomX Therapeutics, Inc. (CTMX)

NMS – Real Time Price. Currency in USD

3.49

+0.04 (1.19%)

Market open: Aug 12, 2026, 2:45 PM EDT

3.50

+0.05 (1.45%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

76M

138M

101M

53M

Cost of goods sold

-1M

-2M

-6M

Gross Profit

75M

136M

99M

47M

Operating expenses (excl. COGS)

-94M

-111M

-106M

-141M

Operating Income

-20M

25M

-6M

-94M

Non-operating income, total

10M

-6M

Pretax income

-17M

32M

-99M

Equity in earnings

Taxes

-238K

-224K

-4M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-17M

32M

-569K

-99M

Discontinued operations

Net income

-17M

32M

-569K

-99M

Dilution adjustment

Preferred dividends

CytomX Therapeutics, Inc. (CTMX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CytomX Therapeutics, Inc. (CTMX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

CytomX Therapeutics, Inc. (CTMX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CytomX Therapeutics, Inc. (CTMX)

Income Statement (Annual)

Income Statement (Annual)